Literature DB >> 2035515

Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinants.

E L Murphy1, J P Figueroa, W N Gibbs, M Holding-Cobham, B Cranston, K Malley, A J Bodner, S S Alexander, W A Blattner.   

Abstract

During 1985 and 1986, the authors measured antibodies to human T-lymphotropic virus type I (HTLV-I) in a cohort of 13,260 Jamaicans from all parts of the island who applied for food-handling licenses. HTLV-I seroprevalence was strongly age and sex dependent, rising from 1.7% (10-19 years) to 9.1% (greater than or equal to 70 years) in men and from 1.9% (10-19 years) to 17.4% (greater than or equal to 70 years) in women. In a logistic regression analysis, women were more likely to be seropositive than were men, and farmers, laborers, and the unemployed were more likely to be HTLV-I seropositive than were those reporting student or professional occupations. In men, African ethnicity was associated with HTLV-I seropositivity in the univariate analysis but was not a risk factor after adjustment for age and sex. There was a trend toward higher age-stratified HTLV-I seroprevalence among younger women who reported more pregnancies, but older multigravidas had lower rates of HTLV-I seropositivity. Persons born outside Jamaica had significantly lower seroprevalence than did those born in Jamaica, but they were of slightly different ethnic and occupational compositions than those born in Jamaica.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2035515     DOI: 10.1093/oxfordjournals.aje.a115824

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  35 in total

1.  Human T cell leukaemia/lymphoma virus infection in pregnant women in the United Kingdom: population study.

Authors:  A E Ades; S Parker; J Walker; M Edginton; G P Taylor; J N Weber
Journal:  BMJ       Date:  2000-06-03

2.  Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica.

Authors:  Yoshimi Enose-Akahata; Anna Abrams; Kory R Johnson; Elizabeth M Maloney; Steven Jacobson
Journal:  Blood       Date:  2012-02-07       Impact factor: 22.113

3.  Turning a blind eye: HTLV-1-associated uveitis in Indigenous adults from Central Australia.

Authors:  Rusheng Chew; Timothy Henderson; Jaskirat Aujla; Eline Whist; Lloyd Einsiedel
Journal:  Int Ophthalmol       Date:  2017-07-28       Impact factor: 2.031

4.  High endemicity of human T-cell lymphotropic virus type 1 among pregnant women in peru.

Authors:  Jorge O Alarcón; Heidi B Friedman; Silvia M Montano; Joseph R Zunt; King K Holmes; Gerald V Quinnan
Journal:  J Acquir Immune Defic Syndr       Date:  2006-08-15       Impact factor: 3.731

5.  Molecular epidemiology and clinical features of human T cell lymphotropic virus type 1 infection in Spain.

Authors:  Ana Treviño; Luiz Carlos Alcantara; Rafael Benito; Estrella Caballero; Antonio Aguilera; José Manuel Ramos; Carmen de Mendoza; Carmen Rodríguez; Juan García; Manuel Rodríguez-Iglesias; Raúl Ortiz de Lejarazu; Lourdes Roc; Patricia Parra; José Eiros; Jorge del Romero; Vincent Soriano
Journal:  AIDS Res Hum Retroviruses       Date:  2014-07-09       Impact factor: 2.205

Review 6.  Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases.

Authors:  Denise Utsch Gonçalves; Fernando Augusto Proietti; João Gabriel Ramos Ribas; Marcelo Grossi Araújo; Sônia Regina Pinheiro; Antônio Carlos Guedes; Anna Bárbara F Carneiro-Proietti
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

Review 7.  Incidence of adult T-cell leukemia/lymphoma in nonendemic areas.

Authors:  Noriaki Yoshida; Dai Chihara
Journal:  Curr Treat Options Oncol       Date:  2015-02

8.  Population differences in immune marker profiles associated with human T-lymphotropic virus type I infection in Japan and Jamaica.

Authors:  Brenda M Birmann; Elizabeth C Breen; Sherri Stuver; Beverly Cranston; Otoniel Martínez-Maza; Kerstin I Falk; Akihiko Okayama; Barrie Hanchard; Nancy Mueller; Michie Hisada
Journal:  Int J Cancer       Date:  2009-02-01       Impact factor: 7.396

9.  Post-transplantation HTLV-1 myelopathy in three recipients from a single donor.

Authors:  J J Zarranz Imirizaldu; J C Gomez Esteban; I Rouco Axpe; T Perez Concha; F Velasco Juanes; I Allue Susaeta; J M Corral Carranceja
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

10.  Human T-lymphotropic virus type I seroprevalence among Japanese Americans.

Authors:  E L Murphy; K F Varney; N T Miyasaki; R J Moore; J I Umekubo; A N Watanabe; H Khayam-Bashi
Journal:  West J Med       Date:  1993-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.